Hiroyuki Ohmori

673 total citations
58 papers, 508 citations indexed

About

Hiroyuki Ohmori is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroyuki Ohmori has authored 58 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 19 papers in Urology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroyuki Ohmori's work include Bladder and Urothelial Cancer Treatments (17 papers), Urinary Bladder and Prostate Research (12 papers) and Urinary and Genital Oncology Studies (12 papers). Hiroyuki Ohmori is often cited by papers focused on Bladder and Urothelial Cancer Treatments (17 papers), Urinary Bladder and Prostate Research (12 papers) and Urinary and Genital Oncology Studies (12 papers). Hiroyuki Ohmori collaborates with scholars based in Japan, Greece and Australia. Hiroyuki Ohmori's co-authors include Yosuke Matsumura, Tomoyasu Tsushima, Hiromi Kumon, Masaya Tsugawa, Masaru Yamaizumi, Makoto Nitta, Yoshitada Ohi, T Shirahama, Suminori Akiba and Suguru Yonezawa and has published in prestigious journals such as Cancer, The Journal of Urology and Urology.

In The Last Decade

Hiroyuki Ohmori

52 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Ohmori Japan 13 240 132 123 109 68 58 508
Toshiaki Shinka Japan 12 224 0.9× 161 1.2× 169 1.4× 127 1.2× 66 1.0× 33 554
Wolfgang Lutzeyer Germany 8 480 2.0× 138 1.0× 97 0.8× 95 0.9× 147 2.2× 14 644
Tomoyuki Ishibe Japan 12 275 1.1× 147 1.1× 164 1.3× 91 0.8× 114 1.7× 75 541
M. Takashi Japan 13 252 1.1× 196 1.5× 152 1.2× 108 1.0× 64 0.9× 37 501
Daniel Burzon United States 6 392 1.6× 119 0.9× 176 1.4× 63 0.6× 106 1.6× 9 616
Thomas Henne Germany 14 131 0.5× 138 1.0× 86 0.7× 65 0.6× 43 0.6× 33 516
L Collste Sweden 17 318 1.3× 124 0.9× 187 1.5× 72 0.7× 126 1.9× 41 749
Taiji Nishimura Japan 11 122 0.5× 94 0.7× 111 0.9× 62 0.6× 106 1.6× 65 413
Tsunetada Yazaki Japan 13 131 0.5× 170 1.3× 187 1.5× 93 0.9× 21 0.3× 58 497
Naotaka Sakamoto Japan 16 244 1.0× 125 0.9× 250 2.0× 220 2.0× 81 1.2× 50 560

Countries citing papers authored by Hiroyuki Ohmori

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Ohmori more than expected).

Fields of papers citing papers by Hiroyuki Ohmori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Ohmori. The network helps show where Hiroyuki Ohmori may publish in the future.

Co-authorship network of co-authors of Hiroyuki Ohmori

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Ohmori. A scholar is included among the top collaborators of Hiroyuki Ohmori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Ohmori. Hiroyuki Ohmori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noma, Kazuhiro, Yoshio Naomoto, Mehmet Gündüz, et al.. (2005). Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines. Oncology Reports. 14(3). 645–50. 12 indexed citations
2.
Miyanaga, Naoto, Hideyuki Akaza, Taiji Tsukamoto, et al.. (1999). Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria. International Journal of Urology. 6(4). 173–177. 49 indexed citations
3.
Tsushima, Tomoyasu, Takanori Murakami, Shin Ebara, et al.. (1998). Partial cystectomy in the treatment of invasive bladder cancer. 60(5). 397–401.
4.
Tsugawa, Masaya, et al.. (1998). Prospective Randomized Comparative Study of Antibiotic Prophylaxis in Urethrocystoscopy and Urethrocystography. International Journal of Urology. 5(5). 441–443. 21 indexed citations
5.
Tsugawa, Masaya, et al.. (1998). ANTIMICROBIAL PROPHYLAXIS IN TRANSURETHRAL RESECTION OF THE PROSTATE. The Japanese Journal of Urology. 89(4). 453–459. 2 indexed citations
6.
Tsushima, Tomoyasu, Yasutomo Nasu, Hiromi Kumon, et al.. (1998). COMBINATION CHEMOTHERAPY WITH CIS-PLATINUM AND IFOSFAMIDE FOR HORMONE UNRESPONSIVE PROSTATE CANCER. The Japanese Journal of Urology. 89(7). 657–664. 5 indexed citations
7.
Tsugawa, Masaya, et al.. (1997). Endoscopic Correction of Vesicoureteral Reflux by Subureteric Teflon (Polytetrafluoroethylene) Injection: Review of 6‐Year Experience. International Journal of Urology. 4(6). 541–545. 5 indexed citations
8.
Kawada, Yukimichi, Takashi Deguchi, Yoshio Aso, et al.. (1994). Dose-finding study on biapenem in complicated urinary tract infection. Chemotherapy. 42(10). 1114–1127. 1 indexed citations
9.
Saika, Takashi, et al.. (1994). OVER‐EXPRESSION OF METALLOTHIONEIN AND DRUG‐RESISTANCE IN BLADDER CANCER. International Journal of Urology. 1(2). 135–139. 18 indexed citations
10.
Watanabe, Toyohiko, et al.. (1993). Pharmacokinetics of vancomycin and dosage planning in patients with renal insufficiency. Chemotherapy. 41(10). 1079–1089. 5 indexed citations
11.
Saika, Takashi, et al.. (1993). TISSUE CONCENTRATION OF INTRAVESICALLY INSTILLED (2^|^Prime;R)-4^|^prime;-0-TETRAHYDROPYRANYL-ADRIAMYCIN OR ADRIAMYCIN IN SUPERFICIAL BLADDER CANCER. The Japanese Journal of Urology. 84(7). 1206–1210. 1 indexed citations
12.
Kawada, Yukimichi, Yoshiaki Kumamoto, Yoshio Aso, et al.. (1992). Comparative study on levofloxacin and ofloxacin in complicated urinary tract infections. Chemotherapy. 40. 230–248. 5 indexed citations
13.
Kawada, Yukimichi, Yoshiaki Kumamoto, Yoshio Aso, et al.. (1992). DOSE-FINDING STUDY ON LEVOFLOXACIN IN COMPLICATED URINARY TRACT INFECTIONS. 40(3). 210–229. 4 indexed citations
14.
Ohi, Yoshitada, Hiroyuki Ohmori, T Shirahama, et al.. (1992). Intravesical instillation of Adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study. Cancer Chemotherapy and Pharmacology. 30(S1). S50–S54. 13 indexed citations
15.
Kumon, Hiromi, et al.. (1991). Flexible Ureteropyeloscopy : Diagnosis and Treatment of Upper Urinary Tumors. 4(1). 103–105. 2 indexed citations
16.
Kumon, Hiromi, et al.. (1988). Pharmacokinetics of imipenem/cilastatin sodium in healthy volunteers and patients with renal insufficiency. Chemotherapy. 36(3). 193–207. 2 indexed citations
17.
Furukawa, Masataka, et al.. (1985). FUNDAMENTAL AND CLINICAL STUDIES ON AZTHREONAM IN COMPLICATED URINARY TRACT INFECTIONS. 33(1). 788–798. 1 indexed citations
18.
Furukawa, Masataka, et al.. (1984). Fundamental and clinical studies on at-2266 in the urological field. Chemotherapy. 32. 796–810. 1 indexed citations
19.
Kumon, Hiromi, et al.. (1983). Pharmacokinetics of antibiotics in patients with impaired renal function. Chemotherapy. 31(8). 815–822. 2 indexed citations
20.
Ohmori, Hiroyuki, Makoto Motoi, Akira Tsutsumi, et al.. (1977). EXTRARENAL RENIN‐SECRETING TUMOR ASSOCIATED WITH HYPERTENSION. Acta Pathologica Japonica. 27(4). 567–586. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiaki Shinka Breakdown of academic impact, for papers by Wolfgang Lutzeyer Breakdown of academic impact, for papers by Tomoyuki Ishibe Breakdown of academic impact, for papers by M. Takashi Breakdown of academic impact, for papers by Daniel Burzon Breakdown of academic impact, for papers by Thomas Henne Breakdown of academic impact, for papers by L Collste Breakdown of academic impact, for papers by Taiji Nishimura Breakdown of academic impact, for papers by Tsunetada Yazaki Breakdown of academic impact, for papers by Naotaka Sakamoto
Rankless by CCL
2026